Skip to main content
PLOS One logoLink to PLOS One
. 2025 Jan 31;20(1):e0316606. doi: 10.1371/journal.pone.0316606

Computational and In silico study of novel fungicides against combating root rot, gray mold, fusarium wilt, and cereal rust

Mollah Naimuzzaman 1,2,#, Md Mahabub Hasan 1,2,#, Ajoy Kumer 3,*, Abu Yousuf Hossin 1, Mohammad Harun-Ur-Rashid 3, Swapan Kumar Roy 1, Abu Noman Faruq Ahmmed 4, Jamal Uddin 5
Editor: Faiz Ahmad Joyia6
PMCID: PMC11785347  PMID: 39888972

Abstract

The exploration of potential candidates for fungicides against four fungal proteins that cause some vital plant diseases, namely Phytophthora capsici, Botrytis cinerea, Fusarium oxysporum f. sp. lycopersici, and Puccinia graminis f. sp. tritici, was conducted using in silico, molecular docking simulations, and molecular dynamic (MD) simulation for selecting the nature of binding affinity with actives sites of proteins. First of all, the DFT was employed to optimize the molecular geometry, and get the prepared optimized ligand. From the DFT data, the chemical descriptors were calculated. Next, two docking tools, such as AutoDock by PyRx and Molecular Docking by Glide from the Schrödinger suite, were used to convey the docking score, and ligand protein interactions against four main proteases, for instance 7VEM, 8H6Q, 8EBB, and 7XDS having name of pathogens: Phytophthora capsici, Botrytis cinerea, Fusarium oxysporum f. sp. lycopersici, and Puccinia graminis f. sp. tritici, respectively. In case of auto dock from PyRx, the fungicides L01, L03, L04, L13, L14, L17, L18, and L19 demonstrated significantly higher affinities for binding to the four fungal pathogens. Surprisingly, it is conveyed that the L03 illustrated the highest binding score against three of 7VEM, 8EBB, and 7XDS proteins and L09 is highest for 8H6Q. However, MD was performed to check the validation and calculation the docking procedure and stability of the protein ligand docked complex accounting of RMSD, RMSF, SASA, Radius of gyration (Rg), Protein secondary structure elements (SSE), Ramachandran plot which confirm that the stability of docked complex is so high, and number of calculating the hydrogen bonds is more than good enough, as a result it is concluded the docking procedure is valid. Finally, Difenoconazole (L03) has been considered as the most promising antifungal drug evaluated from the studies.

Introduction

The broad and negative impact of plant pathogenic fungi on agriculture, ecology, and food security around the world highlights the urgent need for the development of novel fungicides. These fungal diseases are responsible for considerable crop productivity and quality losses, endangering farmers’ livelihoods as well as the global food supply chain [1]. Furthermore, plant diseases induced by fungi contribute to economic instability in agricultural businesses [2], increase pesticide dependency [3], and harm the environment owing to excessive chemical use [4]. The emergence of plant pathogenic fungus exacerbates this problem. Many fungus species have evolved resistance to current fungicides, making conventional chemical treatments ineffective over time. This resistance not only reduces the efficacy of disease control measures, but also requires greater dosages or the use of several fungicides, raising the danger of environmental pollution and harm to non-target organisms [5].

Developing novel fungicides is therefore critical to addressing these difficulties. These innovative methods must be tailored to target fungal diseases with greater precision, reduce environmental impact, and overcome resistance mechanisms. Advanced technologies, including as nanotechnology, bio-based fungicides, and molecular biology techniques, are laying the groundwork for the next generation of fungicides [6]. These techniques allow researchers to design targeted treatments that disrupt fungal life cycles while causing minimum harm to beneficial microbes and the surrounding ecosystem. Furthermore, novel fungicides are critical to guaranteeing sustainable farming operations. By incorporating them into crop protection measures, farmers can minimize their reliance on standard chemical treatments and adopt more environmentally friendly practices. This transition is critical for preserving biodiversity, protecting soil health, and sustaining long-term productivity in agricultural systems [7]. However, the compelling necessity for innovative fungicides arises from the profound impact of plant pathogenic fungi [8], such as Phytophthora capsici(PDB ID: 7vem) [9], Botrytis cinerea (PDB ID: 8H6Q) [10], Fusarium oxysporum f. sp. lycopersici (PDB ID: 8EBB) [11], and Puccinia graminis f. sp. tritici (PDB ID: 7XDS) [12], on global agriculture. These fungal pathogens are responsible for notable crop damages and economic losses [13], with Fusarium oxysporum causing annual economic losses worldwide due to its detrimental effects on tomato production [14]. The escalating resistance to traditional fungicides and their environmental repercussions further emphasize the critical necessity for alternative approaches [15]. Recent progress in computational methodologies, such as molecular docking [16], Molecular Dynamics (MD) simulations [17], Density Functional Theory (DFT) [18], as well as in silico techniques, present promising avenues for the discovery and enhancement of novel fungicidal targets.

Fungal infections significantly impact food security and cause widespread human suffering [19]. The Bengal Famine, aggravated by the fungal pathogen Cochliobolus miyabeanus inducing brown spot disease in rice [20], led to an estimated 2 to 3 million fatalities due to starvation and malnutrition [21,22]. Likewise, the Irish Potato Famine was instigated by Phytophthora infestans, the causative agent of late blight in potatoes [23]. Phytophthora capsici, an oomycete of great concern, induces root rot [24], stem blight, and fruit rot in various crops, notably peppers [25], particularly thriving in warm and moist environments [26]. The pathogen is disseminated through soil and water, utilizing zoospores that travel via soil water films and contaminated irrigation systems [27]. Phytophthora capsici, leading to significant economic repercussions amounting to millions of dollars annually, is especially evident in the United States [28].

The proteins 7VEM, 8H6Q, 8EBB, and 7XDS, derived from various devastating plant pathogens, represent critical targets for computational drug discovery aimed at combating agricultural diseases. The protein 7VEM, identified as NADPH-assisted quinone oxidoreductase from Phytophthora capsici, plays a crucial role in maintaining redox balance essential for the pathogen’s survival and virulence, making it a prime target for inhibitor design. Solved at 2.39 Å resolution with an R-work value of 0.167, its structural fidelity and lack of mutations ensure reliable insights for virtual screening and molecular docking. Similarly, the Class I sesquiterpene synthase BCBOT2 (apo) from Botrytis cinerea (PDB ID: 8H6Q), resolved at 2.00 Å with R-free and R-work values of 0.195 and 0.168 respectively, is vital for sesquiterpene biosynthesis linked to the pathogen’s virulence. Its structural data offer a robust framework for identifying small molecules to disrupt sesquiterpene synthesis, attenuating B. cinerea’s pathogenicity. The SIX6 protein from Fusarium oxysporum f. sp. lycopersici(PDB ID: 8EBB), despite its classification as a protein of unknown function, plays a critical role in the virulence mechanism of this vascular wilt pathogen, which devastates crops like tomatoes. Its high-resolution structure at 1.88 Å, with R-free and R-work values of 0.221 and 0.193, supports molecular docking, virtual screening, and lead optimization to design antifungal agents. Finally, the AvrSr35 effector protein from Puccinia graminisf. sp. tritici(PDB ID: 7XDS), resolved at 2.06 Å with reliable R-values (R-free: 0.287, R-work: 0.257, Observed: 0.258), provides critical insights into wheat stem rust pathogenicity. Its potential as a target for structure-based drug design is underscored by its well-defined active sites and suitability for molecular dynamics simulations and virtual screening. Together, these structural models offer a comprehensive platform for advancing the design of inhibitors to mitigate plant pathogen-induced diseases (Table 1).

Table 1. Protein information.

Title PDB ID:7VEM PDB ID:8H6Q PDB ID:8EBB PDB ID:7XDS
Organism Phytophthora capsici Botrytis cinerei Fusarium oxysporumf. sp.lycopersici Puccinia graminisf. sp.tritici
Resolution 2.39 Å 2.00 Å 1.88 Å 2.06 Å
R-Value Free 0.224 0.195 0.221 0.287
Ramachandran plot, % 89.5 93.8 91.8 94.7
References [57] [58] [59] [60]

Botrytis cinerea, a necrotrophic fungus [29], induces gray mold on more than 200 plant species, such as grapes, strawberries, and tomatoes [30], particularly thriving in environments characterized by high humidity and cool temperatures [31]. Its dissemination occurs through airborne conidia and entry into plants is facilitated through either wounds or natural openings [3235]. The impact on yield can be substantial, with potential losses of up to 50% in crops affected by this pathogen [3537], leading to significant economic loss estimated in the 10-100 billions of dollars globally on an annual basis [3840]. Fusarium oxysporum f. sp. lycopersici, a soil-borne fungal pathogen [4143], induces Fusarium wilt in tomatoes under favorable moist conditions [41,44]. Its dissemination occurs through contaminated soil, water, and plant matter, gaining access through roots and inhabiting the plant’s vascular system [4547]. Severe infestations can lead to yield reductions in agricultural fields, with notable economic repercussions in tomato cultivation areas globally [48,49]. Puccinia graminis f. sp. tritici, a fungal pathogen accountable for stem rust in wheat [50], prospers under warm and moist conditions. Its dissemination occurs via airborne urediniospores capable of long-distance travel, infiltrating plants through stomata [51]. The potential yield reductions can be catastrophic, with losses escalating to 100% during severe outbreaks, significantly impacting worldwide wheat production and food security [52]. The rise of highly virulent strains underscoring the necessity for vigorous resistance breeding and comprehensive disease management tactics [53].The ongoing challenges presented by these fungal pathogens and the encouraging outcomes from computational investigations prompt this study to delve deeper into validating and exploring innovative targets for fungicidal activity through an integrated in silico methodology. Through the utilization of DFT, molecular docking, and MD simulations, the goal is to pinpoint and enhance potent inhibitors characterized by high specificity and minimal off-target effects, which could potentially facilitate the advancement of next-generation fungicides. This holistic approach holds the potential to enhance our comprehension of fungal pathogen mechanisms and make a significant contribution to the realms of sustainable agriculture and global food security.

Methods

Optimization and preparation of ligand

Material Studio 8.0 was used for extensive computational modeling and molecular optimization. The DMol3 algorithm was used for a thorough examination that included the identification of chemical descriptors, quantum characteristics, and geometric optimization. To provide precise and trustworthy findings, this procedure used the DFT functional in conjunction with the BLY3 basis set [5456]. Utilizing the DFT functional, various quantum properties, includinglowest unoccupied molecular orbital(LUMO), highest occupied molecular orbital (HOMO), energy gap, ionization potential (I), electron affinity (A), chemical potential (μ), electronegativity (χ), hardness (η), softness (s), and electrophilicity (ω) were calculated using equations [5]:

Egap=ELUMOEHOMO (1)
I=EHOMO (2)
A=ELUMO (3)
(X) =  I+A2 (4)
(ω)=μ22η (5)
μ=I+A2 (6)
η=IA2 (7)
S=1η (8)

Protein preparation and collection

The meticulous process of selecting and preparing the four fungal proteins, namely 7VEM (Phytophthora capsica), 8H6Q (Botrytis cinerea), 8EBB (Fusarium oxysporum f. sp. lycopersici.), and 7XDS (Puccinia graminis f. sp. tritici), was undertaken to ensure the reliability of the subsequent docking simulations. All of these proteins were found in different plant disease-causing fungi evaluated through the X-ray diffraction method with high stable configuration Ramachandran outliers listed (Table 1). These proteins were obtained from the protein data bank (PDB), which can be accessed at http://www.rcsb.org, on 5th August 2023. The selection of these proteins was based on their biological relevance, specifically their potential association with the study objectives. In order to create a clean protein template for docking using Discovery Studio, co-crystallized ligands, water molecules, and ions were removed. Additionally, the protein structures underwent energy minimization to optimize their conformations and alleviate any steric clashes. This ensured that the selected fungal proteins were properly prepared for accurate and meaningful molecular docking investigations.

Molecular docking and visualization of docking

Molecular docking by PyRx.

The molecular docking analysis was conducted using PyRx software, employing the AutoDock Wizard option. To evaluate the binding affinity between the ligand and individual macromolecules, essential parameters (as detailed in Table 2) were obtained and utilized. In this process, the protein was loaded as a macromolecule, and the ligand was loaded separately. Subsequently, the loaded ligand underwent optimization for maximum energy, considering parameters such as grid surface area, center of grid, and grid dimensions. The goal was to ensure adequate coverage of the total surface area of both the ligand and the protein.The docking process was initiated with the specified parameters outlined (Table 2) within the PyRx software’s AutoDock Wizard option. Following the docking procedure, the resulting ligand-protein docking complex was further analyzed for non-covalent interactions using Discovery Studio visualization [61].

Table 2. Grid box parameters used for docking analysis in this study.
Protein Name with PDB ID Grid Box Size
Center Dimension(Å)
Phytophthora capsici(PDB: 7VEM) X = −0.28 X = 83.52
Y = −25.03 Y = 79.50
Z = −7.46 Z = 72.44
Botrytis cinerea (PDB: 8H6Q) X = 47.34 X = 95.68
Y = 16.24 Y = 97.38
Z = 19.13 Z = 80.33
Fusarium oxysporumf.sp. lycopersici(PDB: 8EBB) X = 2.77 X = 70.97
Y = 17.83 Y = 56.62
Z = −11.09 Z = 67.38
Puccinia graminisf. sp. tritici(PDB: 7XDS) X = 31.47 X = 63.80
T = 75.30 Y = 78.47
Z = 47.42 Z = 107.45

Molecular docking by Glide from Schrodinger suite.

In this research, glide docking was utilized as the molecular docking technique to examine the binding interactions between a variety of ligands and a target protein.The molecular docking was done using Glide tool on Schrodinger suite.For each protein structure, a grid box of 30 × 30 × 30 Å3 with a default inner box (20 × 20 × 20 Å3) was centered on the corresponding ligand [62]. There were however no boundaries and the setting parameters were set to default. Following that, conformational sampling was put into effect to the ligands, and their anticipated binding affinities were then utilized to evaluate them. The Schrödinger software suite includes the Glide docking tool, which enables a systematic search of the conformational space to facilitate a comprehensive examination of ligand-protein interactions. Considerations like attachment modes, bonding by hydrogen patterns, and energetics were thoughtfully taken into account when analyzing the docking results. This method produced insightful information about the connections between structure and activity as well as possible binding locations that are essential for the logical design of novel ligands with enhanced pharmacological profiles. By defining the binding (active) site residues, which were found, the binding site receptor grid for plant pathogenic fungal proteins was created. The docked conformers were evaluated using Glide (G) Score. The G Score is calculated as follows in equation [9]:

G  Score=a×vdW+b×coul+Lipo+HBond+Metal+BuryP+RotB+Site (9)

Wherein, vdW denotes van der Waals energy, Coul denotes Coulomb energy, Lipo denotes lipophilic contact, HBond indicates hydrogen-bonding, Metal indicates metal-binding, BuryP indicates penalty for buried polar groups, RotB indicates penalty for freezing rotatable bonds, Site denotes polar interactions in the active site and the a = 0.065 and b = 0.130 are coefficients of vdW and Coul.

Pharmacokinetics and ADMET studies

The absorption, distribution, metabolism, excretion and toxicity is expressed in shortageby ADMET, which are valuable and necessary factors in the fungicide development process [63,64]. The ADMET criterion was obtained by use of the SwissADME and pkCSMonlinetool:http://biosig.unimelb.edu.au/pkcsm/prediction_single/adme_1643650057.59(accessed from the 10thOctober 2023) [65].

Lipinski rule and pharmacokinetics

SwissADME, accessed on October 9, 2023, was utilized to predict pharmacokinetics and assess fungicide-likeness metrics. This online database, available at http://www.swissadme.ch/index.php [66], is respected for its important and adaptable functions that make information easier to access. In order to fully clarify the fungicide-like properties of different ligands, a large number of pharmacokinetic parameters were determined. These factors included the ligands’ lipophilicity, number of bond rotations (NRB), and molecular weight. The investigation also took into account the quantity of hydrogen bond acceptors (HBA) and donors (HBD). A thorough grasp of the ligands’ potential as fungicides was attained by closely analyzing these variables.

Molecular dynamic

Simulations were conducted using the Desmond software suite (Schrödinger Release 2024-1: Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2024) in accordance with established MD protocols. The molecular system, which consisted of a biologically relevant complex, was prepared using the OPLS-AA force field, and the solvent environment was described using an appropriate water model. To ensure solvent relaxation, the system underwent a staged equilibration process that involved restrained dynamics on the solute. Following this, production MD runs were carried out under NPT conditions, with a finite time step and temperature control. Desmond outputs trajectory files, energy logs, and other data that can be further analyzed or visualized using external tools. Trajectory analysis, performed using Maestro and supplemented by external tools, included measurements, such as root mean square deviation (RMSD), root mean square fluctuation (RMSF), radius of gyration, and energy profiles. Visualization tools were used to examine conformational changes and intermolecular interactions throughout the simulation [67]. This comprehensive computational investigation followed established best practices and parameters, providing a thorough exploration of the dynamic behavior of the molecular system under investigation.

Results and discussion

Optimized structure

The study of a computational procedure to determine the quantum calculations of any chemical species requires the optimization of the molecular structure, which is an important aspect of its structural geometry [68]. Additionally, accurate computational parameters are obtained by determining the most stable configuration of any chemical structure. In this study, all compounds underwent computational optimization using the DFT functional, and their primary and most stable configuration was observed with minimal energy required for optimization. The antifungal ligands are Azoxystrobin(L01), Cyproconazole(L02), Difenoconazole (L03), Tebuconazole (L04), Tricyclazole (L05), Chlorothalonil (L06), Benalaxyl (L07),Bismerthiazol (L08), Carbendazim (L09), Hexaconazole (L10), Thiram (L11), Carboxin (L12), Iprodione (L13), Kresoxim-Methyl (L14), Cymoxanil (L15), Dichloran (L16), Propiconazole (L17), Dimethomorph (L18), Pyraclostrobin (L19) andAmetoctradin (L20) are shown (Figs 1 and S1).

Fig 1. Optimized structure of inhibitors.

Fig 1

HOMO, LUMO, and chemical reactivity descriptors

The calculations of the molecular parameters, including LUMO, HOMO, energy gap (ΔE gap), chemical potential (µ), electronegativity (χ), hardness (η), softness (σ), and electrophilicity (ω), were conducted using the DFT functional, and the results are presented in Table 3. The HOMO-LUMO gap serves as a crucial indicator of chemical reactivity and stability in molecules. In this context, a wider gap suggests higher chemical stability, while a narrower gap implies increased reactivity [6972]. The findings reveal that the HOMO–LUMO gaps range from 2.474 eV to 10.040 eV across all studied ligands. Notably, ligands L01 exhibit minor energy gaps and minimal softness values, indicating their potential for reactivity and reduced stability. In contrast, L14 stands out with the greatest hardness and the largest energy gap, emphasizing its stability.It is observed that the order of the energy gap is L01 < L10 < L13 < L15 < L18 < L19 < L07 < L02 < L09 < L20 < L03 < L05 < L06 < L17 < L08 < L12 < L04 < L14 < L11 < L16. (Table 3) further illustrates that the softness values are approximately 0.228 or less than 0.30, underscoring the potential for faster degradation and disintegration for elements with higher softness values [7376]. Conversely, hardness, a crucial stability indicator, is reflected in the compounds’ resistance to changes in electron configuration [7779]. Higher hardness values signify increased stability and resistance to changes, providing valuable insights into the chemical behavior of these compounds.

Table 3. Data of chemical descriptors.

Ligand LUMO HOMO A = −LUMO I = −HOMO Energy gap =  I−A Chemical Potential (µ) = −I + A/2 Hardness (η) = I−A/2 Electronegativity (x) = I + A/2 Softness (σ) = 1/n Electrophilicity (ω) = µ2/2η
L01 2.131 −9.534 −2.131 9.534 11.665 −3.701 5.832 3.701 0.171 1.174
L02 1.517 −9.034 −1.517 9.034 10.551 −3.758 5.275 3.758 0.189 1.338
L03 0.829 −8.111 −0.829 8.111 8.940 −3.641 4.470 3.641 0.223 1.482
L04 1.361 −9.076 −1.361 9.076 10.437 −3.857 5.218 3.857 0.191 1.425
L05 0.043 −8.943 −0.043 8.943 8.986 −4.450 4.493 4.450 0.222 2.203
L06 0.661 −9.386 −0.661 9.386 10.047 −4.362 5.023 4.362 0.199 1.894
L07 1.893 −8.727 −1.893 8.727 10.620 −3.417 5.310 3.417 0.188 1.099
L08 −1.074 −9.382 1.074 9.382 8.308 −5.228 4.154 5.228 0.240 3.289
L09 1.661 −9.441 −1.661 9.441 11.102 −3.890 5.551 3.890 0.180 1.363
L10 0.819 −8.843 −0.819 8.843 9.662 −4.012 4.831 4.012 0.207 1.665
L11 −2.417 −9.328 2.417 9.328 6.911 −5.872 3.455 5.872 0.289 4.990
L12 0.201 −8.810 −0.201 8.810 9.011 −4.304 4.505 4.304 0.221 2.056
L13 1.176 −9.643 −1.176 9.643 10.819 −4.233 5.409 4.233 0.184 1.656
L14 −1.003 −7.401 1.003 7.401 6.398 −4.202 3.199 4.202 0.312 2.759
L15 1.375 −9.528 −1.375 9.528 10.903 −4.076 5.451 4.076 0.183 1.524
L16 −2.474 −10.040 2.474 10.040 7.566 −6.257 3.783 6.257 0.264 5.174
L17 1.240 −8.880 −1.240 8.880 10.120 −3.820 5.060 3.820 0.197 1.441
L18 1.451 −9.976 −1.451 9.976 11.427 −4.262 5.713 4.262 0.175 1.590
L19 1.241 −9.036 −1.241 9.036 10.277 −3.897 5.138 3.897 0.194 1.478
L20 1.578 −9.137 −1.578 9.137 10.715 −3.779 5.357 3.779 0.186 1.333

Frontier Molecular Orbital: HOMO and LUMO

The frontier molecular orbital (FMO) was used to assess the kinetics, and the engaged regions where the protein could be folded become the active pharmacophore or active functional group. The maximum energy chemical orbital that an electron can occupy in a particular molecule is called the HOMO. Various chemical reactions include electrons in the HOMO, especially electron transfer processes. In addition to acting as the donor of electrons in reactions, the HOMO plays a critical role in nucleophilic assaults by contributing its electron density [8084]. The lowest energy molecular orbital in a molecular structure that is free of electrons is known as the LUMO. During reactions, the LUMO and electrons from the HOMO of another molecule regularly interact. In electrophilic assaults, where it accepts electrons, the LUMO plays a crucial role as the electron acceptor during reactions. The dark blue color indicates the positive terminal of the orbitals in both LUMO, HOMO, while the pink color denotes the negative node. The more minor energy gap assists in the development of fungicide interaction with a protein. From the pictures in (Figs 2 and S2), there is various part of different molecules for HOMO and LUMO.

Fig 2. Frontier molecular orbitals diagram for HOMO and LUMO.

Fig 2

Electrostatic potential map for Frontier Molecular Orbital

Frontier Molecular Orbitals (FMOs) are a set of molecular orbitals that play a crucial role in the reactivity of a molecule. The two most important FMOs are the HOMO and the LUMO showed in the (Figs 3 and S3). These orbitals are involved in various chemical reactions and properties, especially in the context of organic chemistry. Electrostatic potential maps for the HOMO and LUMO can provide valuable insights into the reactivity and electronic structure of a molecule.

Fig 3. Electrostatic potential map for Frontier Molecular Orbital of L14 and L15.

Fig 3

Molecular docking

Auto docking by PyRx.

Molecular docking simulations were conducted to authenticate the pharmacological findings. These simulations confirmed the binding of fungicide compounds with the associated peptide in the presence of four-plant pathogenic fungal proteins, namely Phytophthora capsica, Botrytis cinerea, Fusarium oxysporum f. sp. lycopersici, and Puccinia graminis f. sp. tritici. The primary cause of binding between the compounds and proteins is the hydrogen and hydrophobic bonds, which are demonstrated by molecular docking. The interaction between protein and ligand is crucial for the development of structurally oriented fungicides. It is widely accepted that docking scores higher than -6.00 kcal/mol indicate a standard fungicide [85,86].Additionally, molecular docking is a reliable approach for understanding the engagement of two molecules and identifying the optimal configuration for ligand binding. Through insilico experiments, it was revealed that the fungicide compounds in Table 4 exhibit excellent binding affinity to the target proteins, with values ranging from −3.00 to −9.20 kcal/mol. Among the four fungal pathogens, the highest docking score of −8.20 kcal/mol was observed for Phytophthora capsici(7vem) in L03, while the lowest score of −3.80 kcal/mol was observed in L11. For B. cinerei(8H6Q), the highest docking score of −8.90 kcal/mol was found in L03, and the lowest score of −4.00 kcal/mol was found in L11. For Fusarium oxysporum f. sp. lycopersici(8EBB), the highest docking score of −8.40 kcal/mol was found in L03, and the lowest score of -3.80 kcal/mol was found in L11. Lastly, for Puccinia graminis f. sp. tritici(7XDS), the highest docking score of −9.20 kcal/mol was found in L18, and the lowest score of −4.30 kcal/mol was found in L11. These findings indicate that the fungicides (L01, L03, L04, L13, L14, L17, L18, and L19) exhibit significantly higher binding affinities against the four fungal pathogenic proteins compared to other ligands.

Table 4. Data of binding energy and name of interacted ligand against four fungal proteins in binding affinity (kcal/mol).
S.L Compound Phytophthora capsica (7VEM) B. cinerei(8H6Q)

Fusarium oxysporumf. sp. lycopersici

(8EBB)

Puccinia graminis f. sp. Tritici(7XDS)
L01 Azoxystrobin −7.10 −8.20 −8.10 −7.60
L02 Cyproconazole −6.80 −7.70 −6.60 −7.90
L03 Difenoconazole −8.20 −8.90 −8.40 −7.80
L04 Tebuconazole −6.80 −7.80 −7.20 −6.70
L05 Tricyclazole −6.50 −7.40 −6.30 −7.00
L06 Chlorothalonil −6.00 −6.20 −5.90 −5.90
L07 Benalaxyl −6.50 −8.50 −6.90 −6.70
L08 Bismerthiazol −6.10 −6.20 −6.20 −6.20
L09 Carbendazim −6.30 −7.30 −6.40 −7.00
L10 Hexaconazole −6.30 −7.40 −6.40 −6.60
L11 Thiram −3.80 −4.00 −3.80 −4.30
L12 Carboxin −6.60 −7.20 −6.10 −7.20
L13 Iprodione −8.10 −8.10 −6.80 −7.90
L14 Kresoxim-Methyl −6.60 −8.50 −7.00 −8.30
L15 Cymoxanil −5.60 −6.10 −5.60 −6.10
L16 Dichloran −5.30 −5.90 −5.50 −5.90
L17 Propiconazole −7.20 −7.90 −7.20 −8.40
L18 Dimethomorph −7.60 −8.20 −7.60 −9.20
L19 Pyraclostrobin −8.00 −8.40 −8.10 −8.70
L20 Ametoctradin −6.20 −7.30 −5.50 −6.50

Molecular docking by Glide from Schrodinger suite

Schrodinger suite ligand preparation product, Ligprep was used to prepare high quality, all atom 2D structures. The ligand preparation included 2D–3D conversions, generating variations, correction, verification and optimization of the structures. Receptor grid was generated using Receptor grid generation in the Glide application of Maestro (Schrödinger Release 2024-1: Glide, Schrödinger, LLC, New York, NY, 2024). Through in silico experiments, it was revealed that the fungicide compounds in Table 5 exhibit excellent binding affinity to the target proteins, with values ranging from −2.692 to −7.317 kcal/mol. Among the four fungal pathogens, the highest docking score of −7.317 kcal/mol was observed for Phytophthora capsica (7vem) in L03, while the lowest score of −3.184 kcal/mol was observed in L20. For B. cinerei(8H6Q), the highest docking score of −7.270 kcal/mol was found inL09, and the lowest score of −3.317 kcal/mol was found in L15.For Fusarium oxysporum f. sp. lycopersici (8EBB), the highest docking score of −6.418 kcal/mol was found in L07, and the lowest score of −3.800 kcal/mol was found in L11. Lastly, for Puccinia graminis f. sp. tritici(7XDS), the highest docking score of −5.737 kcal/mol was found in L04, and the lowest score of −2.448 kcal/mol was found in L14.

Table 5. Data of binding energy and name of interacted ligand against 4 plant fungal pathogens in binding affinity (kcal/mol).

S.L Compound Phytophthora capsici(7vem) Botrytis cinerea(8H6Q) Fusarium oxysporumf.sp. Lycopersici(8EBB) Puccinia graminisf.sp. tritici(7XDS)
L01 Azoxystrobin −7.044 −4.631 −4.631 −5.392
L02 Cyproconazole −6.074 −6.109 −5.487 −5.317
L03 Difenoconazole −7.317 −6.499 −5.779 −5.335
L04 Tebuconazole −7.061 −6.731 −5.184 −5.737
L05 Tricyclazole −5.633 −5.707 −5.648 −4.332
L06 Chlorothalonil −5.137 −5.603 −5.065 −3.899
L07 Benalaxyl −5.457 −4.494 −6.418 −2.692
L08 Bismerthiazol −4.294 −3.781 −3.786 −3.729
L09 Carbendazim −5.582 −7.270 −6.042 −4.442
L10 Hexaconazole −5.555 −6.498 −5.712 −3.456
L11 Thiram −4.276 −5.294 −4.099 −3.065
L12 Carboxin −5.760 −6.024 −4.946 −2.933
L13 Iprodione −5.580 −5.331 −5.490 −3.893
L14 Kresoxim-Methyl −5.132 −4.403 −4.896 −2.448
L15 Cymoxanil −3.976 −3.830 −3.317 −3.501
L16 Dichloran −5.585 −5.675 −5.370 −4.097
L17 Propiconazole −6.068 −5.624 −5.468 −3.701
L18 Dimethomorph −6.068 −5.624 −5.468 −5.285
L19 Pyraclostrobin −6.310 −5.697 −5.719 −3.701
L20 Ametoctradin −3.184 −4.232 −4.123 −3.828

A comparative study for docking results

The comparative analysis of docking results obtained from AutoDock by PyRx and Molecular Docking by Glide from the Schrödinger suite underscores the robust binding affinities of certain fungicide compounds with plant pathogenic fungal proteins. In (Fig 4), AutoDock yielded docking scores ranging from −3.00 to −9.20 kcal/mol, with the highest affinity observed for Phytophthora capsici(7vem) with Ligand L03 at −8.20 kcal/mol. Glide results corroborated this finding, producing scores from −2.692 to −7.317 kcal/mol and identifying ligand L03 as having the highest affinity for Phytophthora capsica with a score of −7.317 kcal/mol. Notably, both methods consistently identified L03 as having the strongest binding affinity for this pathogen, highlighting its potential efficacy.

Fig 4. A comparative study of AutoDock by PyRx and Molecular Docking by Glide by Schrödinger suite.

Fig 4

Considering the biological systems in contact with these molecules, ligand L03’s high affinity suggests it could effectively inhibit the growth and proliferation of Phytophthora capsici, a significant plant pathogen. The interaction of L03 with the fungal proteins disrupt critical biological processes within the fungus, thereby mitigating infection and disease spread in plants. However, it is crucial to evaluate the potential impact of L03 on non-target organisms, including beneficial soil microbes, other plant species, and possible environmental persistence. The favorable binding scores indicate that L03 can be developed as an effective fungicide, but comprehensive studies on its environmental behavior, toxicity to non-target species, and overall safety are essential to ensure sustainable and safe agricultural practices. This holistic approach will help in leveraging L03’s potential while minimizing adverse ecological impacts, thereby contributing to effective integrated pest management strategies.

Protein-Ligand interaction for auto docking

The most important factor to take into account when determining which fungicide is most effective is the ligand-protein interaction, which is achieved through the formation of weak bonds or covalent bonds. This interaction provides an approximation of the binding affinity or energy of substances with the proteins of micro pathogens where the molecular docking poses of four plant fungal pathogen proteins with 20 anti-fungal ligands mentioned in (Fig 5). The bond distance was assessed to have a better understanding of the interaction between the molecule and the protein associated with the chosen fungal infections. Substitute data indicates that there are various types of bonds, including hydrophilic, hydrophobic, Van der Waal, and H-bonds. Furthermore, the protein’s locations that the ligand binds are identified. According to the results, the ligand L03 has the most binding sides, with an H-bond count of five and six hydrophobic bonds against the B. cinerei- 8H6Q protein.

Fig 5. Molecular docking poses of four plant fungal pathogen proteins with 20 anti-fungal ligands.

Fig 5

Different poses of docking for protein ligand interaction

PyRx Docking.

The ligand binding sites with receptor was identified with the help of Discovery Studio version 2020, and graphically represents (Figs 69) as well as (S4 Fig). In this case, at first, auto docking has been performed on the protein and ligand to identify the binding sites and obstructing the active site, as well as determining the amino acid residue. The mostly present bond is hydrogen and hydrophobic bond, and they are responsible for docking score variation. After performing molecular docking to predict the interaction between a drug and a protein pocket, several post-docking steps and analyses are typically carried out to understand and evaluate the results. If available, docking results are frequently compared to experimental data to verify the precision of the predictions. A comparison of anticipated binding modes with crystallographic or other experimental structures may be used for validation. To make sure it predicts known binding affinities appropriately, the scoring function utilized during docking is assessed. Future projections may be more accurate if relevant improvements are made. So, what, all drugs are in the molecular pocket of proteins, so the docking procedure, several post-docking steps and analyses are valid.

Fig 6. Molecular docking poses of plant pathogenic fungal protein Phytophthoracapsici (PDB: 7vem) with L03.

Fig 6

Fig 9. Molecular docking poses of plant pathogenic fungal protein Pucciniagraminis f. sp. tritici (PDB: 7XDS) with L18.

Fig 9

Fig 7. Molecular docking poses of plant pathogenic fungal protein Botrytis cinerea (PDB: 8H6Q) with L03.

Fig 7

Fig 8. Molecular docking poses of plant pathogenic fungal protein Fusarium oxysporum f. sp. Lycopersici(PDB: 8EBB) withL01.

Fig 8

Protein ligand interaction from Glide docking

Glide, developed by Schrödinger, is a widely used molecular docking program that predicts the binding mode and affinity of a small molecule (ligand) to a target protein. Analyzing protein-ligand interactions from Glide docking involves examining the docking results and visualizing the binding mode exhibited (Fig 10). Consider the docking score provided by Glide as an estimate of the binding affinity. Lower scores generally indicate better binding.

Fig 10. 2D stick diagram of (A) Azoxystrobin; (B) Tebuconazole; (C) Carbendazim; (D) Iprodione; illustrating hydrogen bonds and pi-pi stacking formed with the amino-acid residues at the binding pocket of Botrytis cinerea (8H6Q).

Fig 10

After performing molecular docking to predict the interaction between a drug and a protein pocket, several post-docking steps and analyses are typically carried out to understand and evaluate the results. Numerous binding poses, or hypothesized binding configurations, have been generated for the drug by the docking software inside the protein pocket. A score has been allocated to each pose, which symbolizes the interaction’s expected binding energy or inclination. On average, lower scores indicate more favorable binding. To make sure it predicts known binding affinities appropriately, the scoring function utilized during docking is assessed. Future projections may be more accurate if relevant improvements are made.

Pharmacokinetics and fungicide-likeness study

Pharmacological fungicide-likeness is a groundbreaking evaluation of the potential of a particular chemical used as an oral medicine with respect to bioavailability. It is estimate that nine out of twelve targeted medicines are not transparently changed due to their negative effect, resulting in significant medication costs, time, and human resources being wasted [87]. This problem occurs due to failure to identify the actual fungicide characteristics. However, by employing a new approach, Lipinski’s five-rule, it is possible to readily test the aspects of lead compounds, such as their bioavailability and G.I. absorption, among other things [88].

From Table 6 it can be seen that all the ligands follow the Lipinski’s five-rule so it can be said that they can remain active as potential drug as small molecules. Each drug can display 0.55 bioavailability score, and they do not violate any conditions of Lipinski’s five-rule.

Table 6. Data of Lipinski rule, pharmacokinetics, and fungicide likeness.

Ligand No Compound Molecular weight, g/mol Number of Rotatable bonds Hydrogen Bond acceptor Hydrogen Bond donor Topological polar surface area (Ų) Lipinski rule Bioavailability score
result violation
L01 Azoxystrobin 403.39 8 8 2 103.56 Yes 0 0.56
L02 Cyproconazole 291.78 5 3 0 50.94 Yes 0 0.55
L03 Difenoconazole 406.26 5 5 1 58.40 Yes 0 0.55
L04 Tebuconazole 307.82 6 3 0 50.94 Yes 0 0.55
L05 Tricyclazole 189.24 0 2 1 58.43 Yes 0 0.55
L06 Chlorothalonil 265.91 0 2 1 47.58 Yes 0 0.55
L07 Benalaxyl 325.40 7 3 0 46.61 Yes 0 0.55
L08 Bismerthiazol 278.40 4 2 2 202.08 Yes 0 0.55
L09 Carbendazim 191.19 3 3 1 67.01 Yes 0 0.55
L010 Hexaconazole 314.21 6 3 0 50.94 Yes 0 0.55
L011 Thiram 240.43 5 0 0 121.26 Yes 0 0.55
L012 Carboxin 235.30 3 2 0 63.63 Yes 0 0.85
L013 Iprodione 330.17 4 3 1 69.72 Yes 0 0.55
L014 Kresoxim-Methyl 313.35 7 5 0 57.12 Yes 0 0.55
L015 Cymoxanil 198.18 6 5 1 103.58 Yes 0 0.55
L016 Dichloran 207.01 1 2 1 71.84 Yes 0 0.55
L017 Propiconazole 342.22 5 4 1 49.17 Yes 0 0.55
L018 Dimethomorph 387.86 6 4 0 48.00 Yes 0 0.55
L019 Pyraclostrobin 387.82 8 5 0 65.82 Yes 0 0.55
L20 Ametoctradin 275.39 8 3 0 69.10 Yes 0 0.55

Bio-availability and toxicity of the fungicides

The bioavailability and toxicity profiles of the twenty ligands reveal significant variations in their absorption, permeability, blood-brain barrier (BBB) penetration, and interactions with P-glycoprotein, cation transporters, and CYP450 enzymes. Most ligands exhibit high absorption in the human intestine, with L02, L03, L04, L05, L09, L12, L13, L14, L15, and L20 approaching or achieving near-complete absorption added in Table 7. Ligand L05 shows excellent BBB penetration, indicating potential central nervous system activity, whereas L01 and L02 exhibit moderate permeability. The interaction with P-glycoprotein varies, with L11 and L12 showing significant inhibition, which could influence drug-drug interactions and efflux. Additionally, the renal organic cation transporter interactions highlight L11 and L15 as noteworthy due to their high scores. Most ligands are substrates for CYP450 enzymes, with L01, L04, L05, L10, L14, L15, L17, and L18 showing notable inhibitory activity, suggesting potential for metabolic interactions. The sub-cellular localization data further suggest diverse intracellular distribution, with L01, L05, L07, L08, L10, L12, and L20 showing significant localization, possibly indicating targeted intracellular effects. Overall, L11 and L12 emerge as particularly potent candidates given their comprehensive favorable profiles across multiple parameters, while others like L01 and L09 demonstrate lower permeability and reactivity, potentially impacting their efficacy and toxicity profiles.

Table 7. Bio-availability and toxicity of the fungicides.

Ligand Absorption Human Intestinal Caco-2 Permeability Blood-Brain Barrier (BBB) P- I glycoprotein inhibitor Cation Transporter Renal Organic P- II glycoprotein substrate Sub-cellular localization Substrate CYP450 2C9 Inhibitor CYP450 1A2
L01 0.5107 0.5663 0.6630 0.7237 0.6170 0.5442 0.8384 0.8069 0.7507
L02 0.9812 0.5617 0.7017 0.6006 0.7102 0.8528 0.5908 0.7075 0.7079
L03 0.9674 0.5825 0.6071 0.7615 0.6265 0.8671 0.4655 0.8009 0.6706
L04 0.9745 0.5742 0.5549 0.8515 0.6636 0.8712 0.6484 0.7393 0.7171
L05 0.9915 0.5075 0.9372 0.5704 0.5913 0.6617 0.5332 0.8212 0.6994
L06 0.8851 0.5476 0.9355 0.6096 0.7651 0.7811 0.5515 0.7726 0.5323
L07 0.8963 0.6421 0.9567 0.8274 0.7913 0.7518 0.5677 0.7434 0.7794
L08 0.6986 0.5799 0.9532 0.5613 0.7639 0.7321 0.5078 0.8535 0.8911
L09 0.9861 0.5288 0.9454 0.7666 0.6042 0.6150 0.6030 0.7474 0.5490
L10 0.9724 0.5886 0.5579 0.6053 0.5000 0.9115 0.4643 0.6683 0.6965
L11 0.9625 0.5000 0.9664 0.9950 0.9064 0.8586 0.4894 0.8228 0.5176
L12 0.9960 0.5708 0.9606 0.9479 0.7373 0.6943 0.6446 0.6602 0.5136
L13 0.0992 0.6004 0.6893 0.9696 0.8378 0.7551 0.6052 0.7278 0.6798
L14 0.9930 0.5480 0.9247 0.7869 0.6053 0.6295 0.7294 0.7948 0.8582
L15 0.9971 0.6077 0.9144 0.7309 0.9168 0.6570 0.8082 0.8151 0.739
L16 0.5153 0.5753 0.7250 0.7997 0.7941 0.5927 0.4554 0.7457 0.5622
L17 0.7399 0.5911 0.6208 0.9683 0.6607 0.8207 0.4652 0.8073 0.6451
L18 0.9758 0.5269 0.7663 0.8813 0.5153 0.8390 0.5495 0.8533 0.7283
L19 0.9799 0.6043 0.6700 0.6214 0.7787 0.5211 0.6468 0.6860 0.6461
L20 1.0000 0.5205 0.9108 0.6888 0.5000 0.5886 0.3373 0.8896 0.5000

Molecular dynamics

Root Mean Square Deviation (RMSD).

For exploring the structural inflexibility and validating the docking scenarios of the topmost ligand-protein complexes Phytophthora capsici(7vem) – Difenoconazole, Botrytis cinerea (8H6Q) – Carbendazim, Fusarium oxysporum f. sp. Lycopersici (8EBB) - Difenoconazole, Puccinia graminis f. sp. tritici (7XDS), MD simulations were performed for 100 ns. By analyzing the C-alpha atom’s RMSD, the firmness of the ligand-protein complexes was assessed.

Protein complexes exhibit initial fluctuations, followed by a transition to a stable state. When the RMSD values fall below 1.8 Å (Angstroms), it typically suggests a robust structural alignment or similarity between the compared structures (Fig 11). An RMSD below 1.8 Å signifies a significant degree of structural similarity, indicating that the examined structures closely resemble each other in terms of both overall form and atomic positions. Attaining RMSD values below 1.8 Å is commonly regarded as an indication of the precision of predicted structures in simulation and molecular modeling studies. This implies a close resemblance between the modeled structure and the reference or experimental structure.

Fig 11. Root Mean Square Deviation (RMSD) of protein-ligand complexes. complexes.

Fig 11

(a) Phytophthoracapsici (7vem) – Difenoconazole, (b) Botrytis cinerea (8H6Q) – Carbendazim, (c) Fusariumoxysporum f. sp. Lycopersici (8EBB) –Difenoconazole, (d) Pucciniagraminis f. sp. tritici (7XDS).

Root Mean Square Fluctuation (RMSF) with respect of residues.

The RMSF with respect to residues is a measure commonly used in the analysis of MD simulations or experimental data of proteins or other biomolecules. It provides insights into the flexibility or mobility of individual amino acid residues within a protein structure. RMSF is calculated as the square root of the average of the squared displacements (or fluctuations) of each residue from its average position over the course of a simulation or experiment. Mathematically, for a protein with N residues, the RMSF of residue i (RMSF and RMSFi) is calculated as:

RMSFi=1nj=1n(xij x¯i)2

Where, n is the number of frames or snapshots in the simulation or experimental data, xij is the position of residue, i in frame j, and xˉi is the average position of residue i over all frames.

In addition, the high RMSF values for certain residues indicate that those residues are more flexible or dynamic. Low RMSF values suggest that those residues are more rigid or less dynamic. RMSF values can be correlated with structural features, functional regions, or interactions within the protein. For example, loops and flexible regions tend to have higher RMSF values compared to core secondary structure elements such as alpha helices and beta strands. It is seen (Fig 12) that the RMSF shows the much less value mean that they are not only excess the value of 2.5 or more. So that it is said that the docked configuration more stable and may be acted as drug after docking accounting by docking. However, it is a valid procedure.

Fig 12. Root Mean Square Fluctuation with respect of residuesprotein-ligand complexes.

Fig 12

(a) Phytophthora capsici (7vem) – Difenoconazole, (b) Botrytis cinerea (8H6Q) – Carbendazim, (c) Fusariumoxysporum f. sp. Lycopersici (8EBB) –Difenoconazole, (d) Pucciniagraminis f. sp. tritici (7XDS).

Protein secondary structure elements (SSE).

Protein secondary structure elements (SSEs) are recurring patterns in protein structures that arise from hydrogen bonding interactions between amino acid residues shown (Fig 13). Common SSEs include alpha helices, beta strands, and loops or turns. In MD analysis, identifying and analyzing SSEs can provide insights into the dynamic behavior and stability of proteins. SSEs can be identified using various algorithms or methods. Commonly used algorithms include DSSP (Define Secondary Structure of Proteins), STRIDE (Structural Identification), and VMD (Visual Molecular Dynamics) among others. These algorithms assign secondary structure elements to each residue in a protein based on the local hydrogen bonding patterns and dihedral angles. Alpha helices are characterized by a regular pattern of hydrogen bonds between residues, resulting in a helical structure. Beta strands form when adjacent segments of the polypeptide chain align in an extended conformation and form hydrogen bonds with each other. Loops or turns are regions of the protein structure that do not form regular hydrogen bonding patterns and connect alpha helices and beta strands. Once SSEs are identified, various analyses can be performed to understand their dynamics and interactions. Quantitative measures such as the length of alpha helices or beta strands, the number of hydrogen bonds within SSEs, and the persistence of SSEs over time can be calculated. Changes in SSEs during the simulation, such as the formation or disruption of helices or strands, can be monitored to study protein folding, unfolding, or conformational changes. SSEs can also be correlated with other structural or dynamic properties, such as solvent accessibility, protein-ligand interactions, or protein-protein interactions. However, SSEs, and SASA mention the stable configuration of docked complexes.

Fig 13. Protein secondary structure elements (SSE) of protein- ligand complexes.

Fig 13

(a) Phytophthoracapsici (7vem) – Difenoconazole, (b) Botrytis cinerea (8H6Q)–Carbendazim, (c) Fusariumoxysporum f. sp. Lycopersici (8EBB) –Difenoconazole, (d) Pucciniagraminis f. sp. tritici (7XDS).

Protein Ligand interaction by bond.

In MD simulations, the interactions between a protein and a ligand (small molecule) are crucial for understanding the mechanism of binding and the stability of the complex. These interactions can involve various types of bonds, including covalent bonds, hydrogen bonds, hydrophobic interactions, and electrostatic interactions. Covalent bonds between the protein and ligand can form when specific reactive groups are present.

Analysis involves identifying the formation or breaking of covalent bonds over the course of the simulation. These interactions are typically less common in non-covalent protein-ligand interactions but are important in certain types of enzyme-substrate interactions or covalent inhibitors. Hydrogen bonds between the protein and ligand play a significant role in stabilizing the complex. Analysis involves identifying hydrogen bond formation and rupture events. Criteria such as distance and angle cutoffs are used to define hydrogen bonds. The frequency, duration, and strength of hydrogen bonds can be analyzed to understand their contribution to binding affinity attached (Fig 14). Hydrophobic interactions occur between non-polar regions of the ligand and protein. Analysis involves identifying hydrophobic contacts based on the proximity of non-polar atoms. Solvent-accessible surface area (SASA) analysis can also provide insights into the burial of hydrophobic residues upon ligand binding.

Fig 14. Protein Ligand interaction by bond of protein- ligand complexes.

Fig 14

(a) Phytophthoracapsici (7vem) – Difenoconazole, (b) Botrytis cinerea (8H6Q)–Carbendazim, (c) Fusariumoxysporum f. sp. Lycopersici (8EBB) –Difenoconazole, (d) Pucciniagraminis f. sp. tritici (7XDS).

Radius of gyration (Rg) of WT, mutations, Solvent-accessible surface area (SASA).

The distribution of an object’s mass around its axis of rotation is measured by the radius of gyration, or Rg. It is frequently used to characterize the spatial distribution of mass in a rigid body or a system of particles in physics and engineering. The radius of gyration for a particular system or object is equal to the square root of the moment of inertia divided by the total mass. In terms of math, it is stated as:

Rg=Im

Here,

Rg is the radius of gyration, I is the moment of inertia of the object or system,m is the total mass.

From the radius of gyration data, it is found that stability and response to external forces under different loading conditions of structure is valid and stable. In MD simulations, the solvent-accessible surface area (SASA) is an essential metric that offers important details on how atoms in a bimolecular system are exposed to the surrounding solvent. SASA is frequently used to investigate how ligands and proteins interact. Variations in the solvent accessibility can reveal areas that are revealed during unbinding or concealed during ligand binding. Finding binding locations and comprehending the energetics of protein-ligand interactions benefit from this. From data of MD simulations, with SASA analysis, it helps to show that the working procedure of docking is valid by experimental data by providing insights into the dynamic behavior of molecules, revealing solvent exposure and flexibility that may not be evident in static structures shown (Fig 15).

Fig 15. Radius of gyration (Rg) of WT, mutations, Solvent-accessible surface area (SASA).

Fig 15

(a) Phytophthoracapsici (7vem) – Difenoconazole, (b) Botrytis cinerea (8H6Q)–Carbendazim, (c) Fusariumoxysporum f. sp. Lycopersici (8EBB) –Difenoconazole, (d) Pucciniagraminis f. sp. tritici (7XDS).

Torsional flexibility in Molecular Docking studies.

Ligands frequently have chemical structures that are flexible, and their torsional flexibility—the capacity to rotate around particular bonds—allows them to take on many conformations. In order for the ligand to locate an energetically advantageous binding position within the protein’s binding site, this flexibility is essential. Torsional flexibility is taken into account by the software while simulating the interaction between a ligand and a protein. In order to investigate several conformations and determine the ideal binding posture inside the protein’s binding site, the ligand is permitted to rotate around its rotatable links.

In MD simulations of protein-ligand interactions, torsion refers to the rotation of specific dihedral angles around covalent bonds within the ligand or the protein. Molecular dynamics simulations involve the computational modeling of the dynamic behavior of molecules over time. Torsional movements are crucial in understanding the conformational changes and flexibility of both the protein and the ligand during their interaction.

First of all, MD simulations track the positions and movements of atoms over time, allowing for the observation of conformational changes. Torsional movements influence the overall flexibility and shape of the protein-ligand complex from the first picture where most of residues are in right shape among 90−180. Secondly, the torsional energy landscape provides insights into the stability and energetically favorable conformations of the protein-ligand complex. All of residues are in lower energy almost zero energy, showing the highest stability having (Fig 16).

Fig 16. Torsional flexibility In Molecular Docking Studies protein- ligand complexes.

Fig 16

protein-ligand complexes (a) Phytophthoracapsici (7vem) – Difenoconazole, (b) Botrytis cinerea (8H6Q)–Carbendazim, (c) Fusariumoxysporum f. sp. Lycopersici (8EBB) –Difenoconazole, (d) Pucciniagraminis f. sp. tritici (7XDS).

Ramachandran plot for Docked protein complex

The Ramachandran plot’s precise characteristics and importance would be described in the pertinent literature or documentation if it is, in fact, a tool or analysis approach used to evaluate the stability of proteins. Studying a variety of elements, including protein folding, thermodynamic characteristics, and interactions with other molecules, is frequently necessary for the stability analysis of proteins. The statistical distribution of the possible combinations of the backbone the dihedral angles υ and ψ is presented in the Ramachandran the following diagram. The Ramachandran plot’s permissible regions, in theory, indicate the potential values of the Phi/Psi angles for an amino acid (X) in an ala-X-ala tripeptide. It can be seen that the plots generally favor amino acid resets above 96%, which give the protein ligand complex a double configuration taken from (Fig 17).

Fig 17. Torsional flexibility In Molecular Docking Studies protein- ligand complexes.

Fig 17

(a) Phytophthoracapsici (7vem) – Difenoconazole, (b) Botrytis cinerea (8H6Q)–Carbendazim, (c) Fusariumoxysporum f. sp. Lycopersici (8EBB) –Difenoconazole, (d) Pucciniagraminis f. sp. tritici (7XDS).

Conclusion

The combination of in silico investigations using AutoDock by PyRx and Molecular Docking by Glide from the Schrödinger suite has yielded valuable insights into potential fungicide candidates against four plant pathogenic fungal proteins -Phytophthora capsici, Botrytis cinerea, Fusarium oxysporum f. sp. lycopersici, and Puccinia graminis f. sp. tritici. The robust molecular docking simulations have convincingly validated the pharmacological findings, demonstrating the binding of various fungicide compounds to their respective target proteins. The main modes of interaction between the compounds and proteins, revealed through these simulations, mostly involve hydrogen and hydrophobic bonds. These interactions play a crucial role in the development of structurally-oriented fungicides, highlighting the importance of understanding the intricate engagement between proteins and ligands. The accepted standard for a fungicide, with docking scores greater than −6.00 kcal/mol, aligns with the results, demonstrating the potential effectiveness of the identified compounds. Among the four fungal pathogens, the fungicides L01, L03, L04, L13, L14, L17, L18, and L19 consistently exhibited significantly higher binding affinities compared to other ligands, with docking scores ranging from −3.00 to −9.20 kcal/mol. In case of DFT, L16 demonstrates the highest electrophilicity (5.174), indicating its strong potential as an electron acceptor, with high chemical stability due to its significant hardness (3.783). Next, L20 shows the highest absorption in the human intestine (1.0000) but has low blood-brain barrier permeability and mixed activity in P-glycoprotein interactions, making it a strong candidate for targeted systemic applications with limited CNS penetration. Ligand L03 demonstrates strong binding affinity against Phytophthora capsica, highlighting its potential as an effective fungicide; however, further studies on environmental impact and non-target toxicity are essential for sustainable agricultural use in both AutoDock and Glide simulations. This convergence of results from different molecular docking methodologies emphasizes the reliability and consistency of L03’s binding affinity for this particular fungal pathogen.

Supporting information

S1 Fig. Optimized structure of molecules.

(DOCX)

pone.0316606.s001.docx (2.3MB, docx)
S2 Fig. Frontier Molecular Orbital of HOMO-LUMO for optimized structure of molecules.

(DOCX)

pone.0316606.s002.docx (4.2MB, docx)
S3 Fig. Electrostatic potential map for optimized structure of molecules.

(DOCX)

pone.0316606.s003.docx (3.9MB, docx)
S4 Fig. Molecular docking pose of molecules.

(DOCX)

pone.0316606.s004.docx (3.7MB, docx)

Acknowledgments

Authors are expressed their thankful to the IUBAT Innovation and Entrepreneurship Center (IIEC), IUBAT—International University of Business Agriculture and Technology, 4-Embankment Drive Road, Sector 10 Uttara Model Town, Dhaka 1230, Bangladesh for their technical supports to carry on this research progress.

Data Availability

All data are in the manuscript and/or supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Fones HN, Bebber DP, Chaloner TM, Kay WT, Steinberg G, Gurr SJ. Threats to global food security from emerging fungal and oomycete crop pathogens. Nat Food. 2020;1(6):332–42. doi: 10.1038/s43016-020-0075-0 [DOI] [PubMed] [Google Scholar]
  • 2.Lengai GMW, Muthomi JW, Mbega ER. Phytochemical activity and role of botanical pesticides in pest management for sustainable agricultural crop production. Scientific Afr. 2020;7:e00239. doi: 10.1016/j.sciaf.2019.e00239 [DOI] [Google Scholar]
  • 3.Popp J, Pető K, Nagy J. Pesticide productivity and food security. a review. Agron Sustain Dev. 2012;33(1):243–55. doi: 10.1007/s13593-012-0105-x [DOI] [Google Scholar]
  • 4.Inamuddin A, Asiri A, Suvardhan K. Green sustainable process for chemical and environmental engineering and science. Elsevier; 2019. [Google Scholar]
  • 5.Bozdogan A. Assessment of total risk on non-target organisms in fungicide application for agricultural sustainability. Sustainability. 2014;6(2):1046–58. doi: 10.3390/su6021046 [DOI] [Google Scholar]
  • 6.Zhang Z, Bills GF, An Z. Advances in the treatment of invasive fungal disease. PLoS Pathog. 2023;19(5):e1011322. doi: 10.1371/journal.ppat.1011322 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Frąc M, Hannula SE, Bełka M, Jędryczka M. Fungal Biodiversity and Their Role in Soil Health. Front Microbiol. 2018;9707. doi: 10.3389/fmicb.2018.00707 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Rameez M, Khan N, Ahmad S, Ahmad MM. Bionanocomposites: a new approach for fungal disease management. Biocat Agri Biotech. 2024;57:103115. doi: 10.1016/j.bcab.2024.103115 [DOI] [Google Scholar]
  • 9.Hausbeck MK, Lamour KH. Phytophthora capsici on vegetable crops: research progress and management challenges. Plant Dis. 2004;88(12):1292–303. doi: 10.1094/PDIS.2004.88.12.1292 [DOI] [PubMed] [Google Scholar]
  • 10.Romanazzi G, Feliziani E. Botrytis cinerea (gray mold). in Postharvest decay. Elsevier. 2014:131–46. [Google Scholar]
  • 11.De Cal A, Pascual S, Larena I, Melgarejo P. Biological control of Fusarium oxysporum f. sp. lycopersici. Plant Pathol. 1995;44(5):909–17. doi: 10.1111/j.1365-3059.1995.tb02750.x [DOI] [Google Scholar]
  • 12.Roelfs AP. An international system of nomenclature for Puccinia graminisf. sp.tritici. Phytopathol. 1988;78(5):526. doi: 10.1094/phyto-78-526 [DOI] [Google Scholar]
  • 13.Saberi Riseh R, Vatankhah M, Hassanisaadi M, Barka EA. Unveiling the role of hydrolytic enzymes from soil biocontrol bacteria in sustainable phytopathogen management. Front Biosci (Landmark Ed). 2024;29(3):105. doi: 10.31083/j.fbl2903105 [DOI] [PubMed] [Google Scholar]
  • 14.Adisa IO. Potential of nanoscale elements to control Fusarium wilt disease in tomato (Solanum lycopersicum), enhance macronutrient use efficiency, and increase its yield. The University of Texas at El Paso; 2019. [Google Scholar]
  • 15.Garvey M, Rowan NJ. Pathogenic drug resistant fungi: a review of mitigation strategies. Int J Mol Sci. 2023;24(2):1584. doi: 10.3390/ijms24021584 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kawsar SMA, Almalki FA, Hadd TB, Laaroussi H, Khan MAR, Hosen MA, et al. Potential antifungal activity of novel carbohydrate derivatives validated by POM, molecular docking and molecular dynamic simulations analyses. Molecular Simula. 2022;49(1):60–75. doi: 10.1080/08927022.2022.2123948 [DOI] [Google Scholar]
  • 17.Rathod S, Bhande D, Pawar S, Gumphalwad K, Choudhari P, More H. Identification of potential hits against fungal lysine deacetylase Rpd3 via molecular docking, molecular dynamics simulation, DFT, In-Silico ADMET and drug-likeness assessment. Chem Afr. 2023;7(2):1151–64. doi: 10.1007/s42250-023-00766-5 [DOI] [Google Scholar]
  • 18.Singh B, et al. Evaluating terrestrol a as an inhibitor against SARS‐CoV‐2 and invasive fungal pathogens: a comprehensive computational analysis. Chem Select. 2024;9(14):e202304761. [Google Scholar]
  • 19.Xu J. Assessing global fungal threats to humans. mLife. 2022;1(3):223–40. doi: 10.1002/mlf2.12036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Sudhakar C, Sawant K, Kumar S, Shukla M, Rana M, Srivastava S. Brown spot: an embryonic disease of rice; 2022. [Google Scholar]
  • 21.Ahn I-P. Glufosinate ammonium-induced pathogen inhibition and defense responses culminate in disease protection in bar-transgenic rice. Plant Physiol. 2008;146(1):213–27. doi: 10.1104/pp.107.105890 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Vurro M, Bonciani B, Vannacci G. Emerging infectious diseases of crop plants in developing countries: impact on agriculture and socio-economic consequences. Food Sec. 2010;2(2):113–32. doi: 10.1007/s12571-010-0062-7 [DOI] [Google Scholar]
  • 23.Lal M, Sharma S, Yadav S, Kumar S. Management of late blight of potato. Potato-from Incas to All Over the World. 2018:83–106. [Google Scholar]
  • 24.Umadevi P, Anandaraj M. Proteomic analysis of the tripartite interaction between black pepper, Trichoderma harzianum and Phytophthora capsici provides insights into induced systemic resistance mediated by Trichoderma spp.. Eur J Plant Pathol. 2019;154(3):607–20. doi: 10.1007/s10658-019-01685-3 [DOI] [Google Scholar]
  • 25.Hua GKH, Ji P, Culbreath AK, Ali ME. Comparative study of phosphorous-acid-containing products for managing phytophthora blight of bell pepper. Agronomy. 2022;12(6):1293. doi: 10.3390/agronomy12061293 [DOI] [Google Scholar]
  • 26.Hannukkala AO. Examples of alien pathogens in Finnish potato production-their introduction, establishment and consequences; 2011. [Google Scholar]
  • 27.Cayanan DF. Sensitivity of nursery plants to free chlorine in the management of plant pathogens in irrigation water. University of Guelph; 2008. [Google Scholar]
  • 28.Lozada DN, Nunez G, Lujan P, Dura S, Coon D, Barchenger DW, et al. Genomic regions and candidate genes linked with Phytophthora capsici root rot resistance in chile pepper (Capsicum annuum L.). BMC Plant Biol. 2021;21(1):601. doi: 10.1186/s12870-021-03387-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Govrin EM, Levine A. The hypersensitive response facilitates plant infection by the necrotrophic pathogen Botrytis cinerea. Curr Biol. 2000;10(13):751–7. doi: 10.1016/s0960-9822(00)00560-1 [DOI] [PubMed] [Google Scholar]
  • 30.Chen X, Wang Y, Gao Y, Gao T, Zhang D. Inhibitory abilities of bacillus isolates and their culture filtrates against the gray mold caused by botrytis cinerea on postharvest fruit. Plant Pathol J. 2019;35(5):425–36. doi: 10.5423/PPJ.OA.03.2019.0064 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Li T, Liu R, Liu Z, Chang J, Li J. Effects of intermittent temperature and humidity regulation on tomato gray mold. Plant Dis. 2023;107(8):2335–45. doi: 10.1094/PDIS-10-22-2339-RE [DOI] [PubMed] [Google Scholar]
  • 32.Leyronas C, Fatnassi H, Bardin M, Boulard T, Nicot PC. Modelling botrytis cinerea spore exchanges and production in unheated greenhouses. J Plant Pathol. 2011:407–14. [Google Scholar]
  • 33.Kulkarni SJ. An insight into research and investigations of gray mold focused on Botrytis cinerea. in Driving factors for venture creation and success in agricultural entrepreneurship. 2022:273–89. [Google Scholar]
  • 34.Sammonds J. Pre-infection processes of Botryosphaeriaceae species conidia. Lincoln University; 2015. [Google Scholar]
  • 35.Elmer PA, Michailides TJ. Epidemiology of Botrytis cinerea in orchard and vine crops. in Botrytis: Biology, Pathology and Control. Springer; 2007:243–72. [Google Scholar]
  • 36.Poveda J, Barquero M, González-Andrés F. Insight into the microbiological control strategies against botrytis cinerea using systemic plant resistance activation. Agronomy. 2020;10(11):1822. doi: 10.3390/agronomy10111822 [DOI] [Google Scholar]
  • 37.Davidson JA, Pande S, Bretag TW, Lindbeck KD, Krishna-Kishore G. Biology and management of Botrytis spp. in legume crops. in Botrytis: biology, pathology and control. 2007:295–318. [Google Scholar]
  • 38.Raynaldo FA, Xu Y, , Wang Q, Wu B, Li D. Biological control and other alternatives to chemical fungicides in controlling postharvest disease of fruits caused by <i>Alternaria alternata</i> and <i>Botrytis cinerea</i>. Food Innov Adv. 2024;3(2):135–43. doi: 10.48130/fia-0024-0014 [DOI] [Google Scholar]
  • 39.Bojkov G. Gray Mold (Botrytis Cinerea) at Vines. USA: Scientific Research Publishing, Inc; 2022. [Google Scholar]
  • 40.Wakeham A, Langton A, Adams S, Kennedy R. Interface of the environment and occurrence of Botrytis cinerea in pre-symptomatic tomato crops. Crop Protect. 2016;90:27–33. doi: 10.1016/j.cropro.2016.08.014 [DOI] [Google Scholar]
  • 41.Maurya S, Dubey S, Kumari R, Verma R. Management tactics for fusarium wilt of tomato caused by Fusarium oxysporum f. sp. lycopersici (Sacc.): a review. Management. 2019;4(5):1–7. [Google Scholar]
  • 42.Kavroulakis N, Ntougias S, Besi MI, Katsou P, Damaskinou A, Ehaliotis C, et al. Antagonistic bacteria of composted agro-industrial residues exhibit antibiosis against soil-borne fungal plant pathogens and protection of tomato plants from Fusarium oxysporum f.sp. radicis-lycopersici. Plant Soil. 2010;333(1–2):233–47. doi: 10.1007/s11104-010-0338-x [DOI] [Google Scholar]
  • 43.Kumari SMP, Prabina BJ. Protection of tomato, Lycopersicon esculentum from wilt pathogen, Fusarium oxysporum f. sp. lycopersici by arbuscular mycorrhizal fungi, Glomus sp. Int J Curr Microbiol Appl Sci. 2019;8:1368–78. [Google Scholar]
  • 44.Bawa I. Management strategies of Fusarium wilt disease of tomato incited by Fusarium oxysporum f. sp. lycopersici (Sacc.) a review. Int J Adv Acad Res. 2016;2(5). [Google Scholar]
  • 45.Srinivas C, Nirmala Devi D, Narasimha Murthy K, Mohan CD, Lakshmeesha TR, Singh B, et al. Fusarium oxysporum f. sp. lycopersici causal agent of vascular wilt disease of tomato: Biology to diversity- a review. Saudi J Biol Sci. 2019;26(7):1315–24. doi: 10.1016/j.sjbs.2019.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Devi S. 14. Fusarium wilt of brinjal. n.d. [Google Scholar]
  • 47.Thatcher LF, Kidd BN, Kazan K. Belowground defence strategies against Fusarium oxysporum. Belowground defence strategies in plants. 2016:71–98. [Google Scholar]
  • 48.López-Zapata S, García-Jaramillo DJ, López WR, Ceballos-Aguirre N. Tomato (Solanum lycopersicum L.) and Fusarium oxysporum f. sp. lycopersici interaction. a review. Revista UDCA Actualidad & Divulgación Científica. 2021;24(1). [Google Scholar]
  • 49.Beyan A, Seid A, Shifa H. Response of tomato genotypes to Meloidogyne javanica and Fusarium oxysporum f. sp. lycopersici co-infestation under glasshouse conditions; 2019. [Google Scholar]
  • 50.Gao F, Wu X, Sun H, Wang Z, Chen S, Zou L, et al. Identification of Stem Rust Resistance Genes in Triticum Wheat Cultivars and Evaluation of Their Resistance to Puccinia graminis f. sp. tritici. Agriculture. 2024;14(2):198. doi: 10.3390/agriculture14020198 [DOI] [Google Scholar]
  • 51.Brueggeman RS, Solanki S, Ameen G, Effertz K, Poudel RS, Karakaya A. Fungal diseases affecting barley. in Achieving sustainable cultivation of barley. Burleigh Dodds Science Publishing. 2020:265–322. [Google Scholar]
  • 52.Alkhalifah DHM, Damra E, Melhem MB, Hozzein WN. Fungus under a changing climate: modeling the current and future global distribution of fusarium oxysporum using geographical information system data. Microorganisms. 2023;11(2):468. doi: 10.3390/microorganisms11020468 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Ontoy JC, Ham JH. Mapping and omics integration: towards precise rice disease resistance breeding. Plants. 2024;13(9):1205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Kohn W, Becke AD, Parr RG. Density functional theory of electronic structure. J Phys Chem. 1996;100(31):12974–80. doi: 10.1021/jp960669l [DOI] [Google Scholar]
  • 55.Fukui K, Pullman B. Horizons of quantum chemistry. Springer; 1980. doi: 10.1007/978-94-009-9027-2 [DOI] [Google Scholar]
  • 56.Parr RG, Yang W. Density functional approach to the frontier-electron theory of chemical reactivity. J Am Chem Soc. 1984;106(14):4049–50. doi: 10.1021/ja00326a036 [DOI] [Google Scholar]
  • 57.Yang C, Huang Z, Zhang X, Zhu C. Structural Insights into the NAD(P)H:Quinone Oxidoreductase from Phytophthora capsici. ACS Omega. 2022;7(29):25705–14. doi: 10.1021/acsomega.2c02954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Lou T, et al. Structural insights into three sesquiterpene synthases for the biosynthesis of tricyclic sesquiterpenes and chemical space expansion by structure-based mutagenesis. J Am Chem Soc. 2023;145(15):8474–85. [DOI] [PubMed] [Google Scholar]
  • 59.Yu DS. The structural repertoire of Fusarium oxysporum f. sp. lycopersici effectors revealed by experimental and computational studies. BioRxiv. 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Zhao Y-B, Liu M-X, Chen T-T, Ma X, Li Z-K, Zheng Z, et al. Pathogen effector AvrSr35 triggers Sr35 resistosome assembly via a direct recognition mechanism. Sci Adv. 2022;8(36):eabq5108. doi: 10.1126/sciadv.abq5108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Spassov V, Yan L. Accelrys software inc., discovery studio modeling environment, release 4.0. Proteins: Str, Fun, and Bioinform. 2013;81:704–14. [Google Scholar]
  • 62.Sándor M, Kiss R, Keseru GM. Virtual fragment docking by Glide: a validation study on 190 protein-fragment complexes. J Chem Inf Model. 2010;50(6):1165–72. doi: 10.1021/ci1000407 [DOI] [PubMed] [Google Scholar]
  • 63.Tsaioun K, Blaauboer BJ, Hartung T. Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods. ALTEX. 2016;33(4):343–58. doi: 10.14573/altex.1610101 [DOI] [PubMed] [Google Scholar]
  • 64.Chandrasekaran SB, Abed N, Al-Attraqchi O, Kuche K, Tekade RK. Computer-aided prediction of pharmacokinetic (ADMET) properties. in Dosage Form Design Parameters. 2018:731–55. [Google Scholar]
  • 65.Pires DEV, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066–72. doi: 10.1021/acs.jmedchem.5b00104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717. doi: 10.1038/srep42717 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Bowers KJ. Scalable algorithms for molecular dynamics simulations on commodity clusters. in Proceedings of the 2006 ACM/IEEE Conference on Supercomputing. 2006:84-es. [Google Scholar]
  • 68.López J, Anitescu C, Valizadeh N, Rabczuk T, Alajlan N. Structural shape optimization using Bézier triangles and a CAD-compatible boundary representation. Eng Comp. 2019;36(4):1657–72. doi: 10.1007/s00366-019-00788-z [DOI] [Google Scholar]
  • 69.Kumer A, Ahmed B, Sharif M, Al-Mamun A. A theoretical study of aniline and nitrobenzene by computational overview. Asian J Phy Chem Sci. 2017;4(2):1–12. [Google Scholar]
  • 70.Kumer A, Paul S, Sarker MN, Islam MJ. The prediction of thermo physical, vibrational spectroscopy, chemical reactivity, biological properties of morpholinium borate, phosphate, chloride and bromide ionic liquid: a DFT study. Inter J New Chem. 2019;6(4):236–53. [Google Scholar]
  • 71.Kumer A, Sarker MN, Paul S. The theoretical investigation of HOMO, LUMO, thermophysical properties and QSAR study of some aromatic carboxylic acids using HyperChem programming. Intern J Chem Tech. 2019;3(1):26–37. doi: 10.32571/ijct.478179 [DOI] [Google Scholar]
  • 72.Kumer A, Sarker MN, Paul S, Zannat A. The theoretical prediction of thermophysical properties, HOMO, LUMO, QSAR and Biological Indics of Cannabinoids (CBD) and Tetrahhdrocannabinol (THC) by computational chemistry. Adv J Chem A. 2019;2(3):190–202. doi: 10.33945/sami/ajca.2019.2.190202 [DOI] [Google Scholar]
  • 73.Akash S, Aovi FI, Azad MAK, Kumer A, Chakma U, Islam MR, et al. A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives. PLoS One. 2023;18(10):e0283271. doi: 10.1371/journal.pone.0283271 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Hashem HE, Ahmad S, Kumer A, Bakri YE. In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2. Sci Rep. 2024;14(1):1152. doi: 10.1038/s41598-024-51443-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Kobir ME, Ahmed A, Roni MAH, Chakma U, Amin MR, Chandro A, et al. Anti-lung cancer drug discovery approaches by polysaccharides: an in silico study, quantum calculation and molecular dynamics study. J Biomol Struct Dyn. 2023;41(14):6616–32. doi: 10.1080/07391102.2022.2110156 [DOI] [PubMed] [Google Scholar]
  • 76.Rani M, Nath A, Kumer A. In-silico investigations on the anticancer activity of selected 2-aryloxazoline derivatives against breast cancer. J Biomol Struct Dyn. 2023;41(17):8392–401. doi: 10.1080/07391102.2022.2134208 [DOI] [PubMed] [Google Scholar]
  • 77.Kawsar S, Kumer A. Computational investigation of methyl α-D-glucopyranoside derivatives as inhibitor against bacteria, fungi and COVID-19 (SARS-2). J Chile Chem Soc. 2021;66(2):5206–14. [Google Scholar]
  • 78.Kumer A, Khan MW. The effect of alkyl chain and electronegative atoms in anion on biological activity of anilinium carboxylate bioactive ionic liquids and computational approaches by DFT functional and molecular docking. Heliyon. 2021;7(7):e07509. doi: 10.1016/j.heliyon.2021.e07509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Kumer A, Khan MW. Synthesis, characterization, antimicrobial activity and computational exploration of ortho toludinium carboxylate ionic liquids. J Molecular Str. 2021;1245:131087. doi: 10.1016/j.molstruc.2021.131087 [DOI] [Google Scholar]
  • 80.Hoque M, Kumer A, Hussen MS, Khan MW. Theoretical evaluation of 5,6-diaroylisoindoline-1,3-dione as potential carcinogenic kinase PAK1 inhibitor: DFT calculation, molecular docking study and ADMET prediction. Inte J Adv Biologi Biomedi Res. 2021;9(1):77–104. [Google Scholar]
  • 81.Islam MJ, Sarker MN, Kumer A, Paul S. The evaluation and comparison of thermo-physical, chemical and biological properties of palladium (II) complexes on binuclear amine ligands with different anions by DFT study. Inte J Adv Biologi Biomedi Res. 2019;7(4):315–34. [Google Scholar]
  • 82.Kumer A, Chakma U, Chandro A, Howlader D, Akash S, Kobir MdE, et al. Modified D-Glucofuranose computationally screening for inhibitor of breast cancer and triple breast cancer: chemical descriptor, molecular docking, molecular dynamics And QSAR. J Chil Chem Soc. 2022;67(3):5623–35. doi: 10.4067/s0717-97072022000305623 [DOI] [Google Scholar]
  • 83.Kumer A, Chakma U, Rana MM, Chandro A, Akash S, Elseehy MM, et al. Investigation of the new inhibitors by sulfadiazine and modified derivatives of α-D-glucopyranoside for white spot syndrome virus disease of shrimp by. In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study. Molecules. 2022;27(12):3694. doi: 10.3390/molecules27123694 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Kumer A, Jahidul M, Paul S. Effect of external electric field and temperature on entropy, heat of capacity, and chemical reactivity with QSAR study of morphonium chloride and nitrous ionic liquids crystal using DFT. Chem Methodolo. 2020;4:595–604. [Google Scholar]
  • 85.Cheng K, Zheng Q-Z, Qian Y, Shi L, Zhao J, Zhu H-L. Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics. Bioorg Med Chem. 2009;17(23):7861–71. doi: 10.1016/j.bmc.2009.10.037 [DOI] [PubMed] [Google Scholar]
  • 86.Hermann T, Westhof E. Docking of cationic antibiotics to negatively charged pockets in RNA folds. J Med Chem. 1999;42(7):1250–61. doi: 10.1021/jm981108g [DOI] [PubMed] [Google Scholar]
  • 87.Athar M, Sona AN, Bekono BD, Ntie-Kang F. Fundamental physical and chemical concepts behind “drug-likeness” and “natural product-likeness”. Phys Sci Rev. 2019;4(12):. doi: 10.1515/psr-2018-0101 [DOI] [Google Scholar]
  • 88.Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deli Rev. 1997;23(1–3):3–25. [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Faiz Ahmad Joyia

8 May 2024

PONE-D-24-06911Inquisition of Novel Targets for Potential Fungicides against four plant pathogenic fungal by in silico, molecular docking, Molecular dynamics and DFTPLOS ONE

Dear Dr. Kumer,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

1. Title of the manuscript needs revision. It looks incomplete as "four plant pathogenic fungal".

2. The manuscript lacks discussion on the bio-availability and toxicity of the said fungicides.

3. More data has been demanded by a Reviewer-2 and it is doable to use more in silico tools to elaborate the results especially the impact  of these fungicides on living cells  if these fungicides get enter into the cells.

4. Results lack description keeping in view the biological systems that may come in contact with these molecules..

==============================

Please submit your revised manuscript by Jun 22 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Faiz Ahmad Joyia, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

3. Thank you for stating the following in your Competing Interests section:  

[N/A]. 

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state ""The authors have declared that no competing interests exist."", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now 

 This information should be included in your cover letter; we will change the online submission form on your behalf.

4. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement.

5. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information

Additional Editor Comments:

Comments by Reviewer 2.

Author should add more in-silico data from multiple software and tools to evaluate these findings. This is very limited data for such important fungal pathogens.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The review for the manuscript entitled “Inquisition of Novel Targets for Potential Fungicides against four plant pathogenic fungal by in silico, molecular docking, Molecular dynamics and DFT”.

Authors have explored potential candidates for fungicides against 4 fungal proteins. They have used in sillico, molecular docking simulations, and molecular dynamic simulation for selecting the nature inhibitors against fungal pathogens.

In opinion:

The manuscript title succinctly reflects the research's core. It's a meticulously prepared document:

The introduction furnishes a thorough overview, laying the groundwork for the study.

The methods section meticulously explains the procedures, ensuring reproducibility for fellow researchers.

Results and figures are clearly presented, facilitating comprehension of the findings.

The discussion and conclusion sections adeptly analyze the results, offering valuable insights into the study's implications.

Reviewer #2: Author should add more in-silico data from multiple software and tools to evaluate these findings. This is very limited data for such important fungal pathogens. Author should start with one fungal pathogen with the fungicide first.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Subhash Chandra

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: comments.docx

pone.0316606.s005.docx (12.9KB, docx)

Decision Letter 1

Faiz Ahmad Joyia

18 Nov 2024

PONE-D-24-06911R1Inquisition of Novel Fungicidal Targets for Combating Root Rot, Gray Mold, Fusarium Wilt, and Cereal Rust through In Silico Techniques, Molecular Docking, Dynamics, and DFT AnalysisPLOS ONE

Dear Dr. Kumer, 

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================Revised version of the manuscript is satisfactory. The authors are requested to perform minor revisions as suggested by the authors.

==============================

Please submit your revised manuscript by Jan 02 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Faiz Ahmad Joyia, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

The revised version of manuscript is satisfactory. The authors are requested to perform minor revision as suggested by the reviewers.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: N/A

Reviewer #3: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: No

Reviewer #3: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: This revised draft still needs formatting and grammatical correction throughout the draft. For example, Figure 6 to 9 legend font size is different. Give brief description for all figure legends. Title under each figure does not convey any information.

Cite the in-silico reference https://doi.org/10.55730/1300-011x.3191 with REF 9 for the statement “particularly in silico techniques like molecular docking[9]”

Do not use abbreviations in figure legend. For example, figure 2 legend, HOMO and LUMO. Write full name.

Check the formatting for the heading “A comparative study for docking Results”.

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #2: Yes:  Hira Kamal

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer Comments_PONE-D-24-06911.docx

pone.0316606.s006.docx (13.3KB, docx)
PLoS One. 2025 Jan 31;20(1):e0316606. doi: 10.1371/journal.pone.0316606.r003

Author response to Decision Letter 1


10 Dec 2024

The paper presents a comprehensive computational study on the identification of potential fungicides against four fungal proteins. The authors employ a range of computational methods, including molecular docking, molecular dynamics simulations, and pharmacokinetics studies. However here are some suggestions

1. Title should be shortened and more concise.

Answer: It has revised and have made short as

“Computational and In silico study of Novel Fungicides against Combating Root Rot, Gray Mold, Fusarium Wilt, and Cereal Rust.”

2. Should add relevant keywords that accurately reflect the content of the paper.

Answer: It has revised and added as

Density Functional Theory, HOMO, LUMO, Molecular docking, ADMET and Molecular Dynamics

3. Don’t use jargon in title

Answer: It has revised and sincerely removed.

4. Add description or full form of these proteins i.e. 7VEM, 8H6Q, 8EBB, 7XDS, at

least at first time use.

Answer: It has revised and added as:

The proteins 7VEM, 8H6Q, 8EBB, and 7XDS, derived from various devastating plant pathogens, represent critical targets for computational drug discovery aimed at combating agricultural diseases. The protein 7VEM, identified as NADPH-assisted quinone oxidoreductase from Phytophthora capsici, plays a crucial role in maintaining redox balance essential for the pathogen's survival and virulence, making it a prime target for inhibitor design. Solved at 2.39 Å resolution with an R-work value of 0.167, its structural fidelity and lack of mutations ensure reliable insights for virtual screening and molecular docking. Similarly, the Class I sesquiterpene synthase BCBOT2 (apo) from Botrytis cinerea (PDB ID: 8H6Q), resolved at 2.00 Å with R-free and R-work values of 0.195 and 0.168 respectively, is vital for sesquiterpene biosynthesis linked to the pathogen's virulence. Its structural data offer a robust framework for identifying small molecules to disrupt sesquiterpene synthesis, attenuating B. cinerea's pathogenicity. The SIX6 protein from Fusarium oxysporum f. sp. lycopersici (PDB ID: 8EBB), despite its classification as a protein of unknown function, plays a critical role in the virulence mechanism of this vascular wilt pathogen, which devastates crops like tomatoes. Its high-resolution structure at 1.88 Å, with R-free and R-work values of 0.221 and 0.193, supports molecular docking, virtual screening, and lead optimization to design antifungal agents. Finally, the AvrSr35 effector protein from Puccinia graminis f. sp. tritici (PDB ID: 7XDS), resolved at 2.06 Å with reliable R-values (R-free: 0.287, R-work: 0.257, Observed: 0.258), provides critical insights into wheat stem rust pathogenicity. Its potential as a target for structure-based drug design is underscored by its well-defined active sites and suitability for molecular dynamics simulations and virtual screening. Together, these structural models offer a comprehensive platform for advancing the design of inhibitors to mitigate plant pathogen-induced diseases Table 1.

Table 1. Protein information.

Title PDB ID:7VEM PDB ID:8H6Q PDB ID:8EBB PDB ID:7XDS

Organism Phytophthora capsici Botrytis cinerea Fusarium oxysporum f. sp.lycopersici Puccinia graminis f. sp. tritici

Resolution 2.39 Å 2.00 Å 1.88 Å 2.06 Å

R-Value Free 0.224 0.195 0.221 0.287

Ramachoron plot, % 89.5 93.8 91.8 94.7

5. Also add sequence characterization study for the given proteins

Answer: It has revised and added which is almost relevant answer of question 4.

6. Add details of figure in legends

Answer: Answer: It has revised and added as:

The study of a computational procedure to determine the quantum calculations of any chemical species requires the optimization of the molecular structure, which is an important aspect of its structural geometry.

Additionally, accurate computational parameters are obtained by determining the most stable configuration of any chemical structure. In this study, all compounds underwent computational optimization using the DFT functional, and their primary and most stable configuration was observed with minimal energy required for optimization. The antifungal ligands are Azoxystrobin(L01), Cyproconazole(L02), Difenoconazole (L03), Tebuconazole (L04), Tricyclazole (L05), Chlorothalonil (L06), Benalaxyl (L07),Bismerthiazol (L08), Carbendazim (L09), Hexaconazole (L10), Thiram (L11), Carboxin (L12), Iprodione (L13), Kresoxim-Methyl (L14), Cymoxanil (L15), Dichloran (L16), Propiconazole (L17), Dimethomorph (L18), Pyraclostrobin (L19) andAmetoctradin (L20) are shown in Fig 1 and supplementary 1.

L01 L02

L03 L04

Attachment

Submitted filename: Reviewer Comments_PONE-D-24-06911 (R2).docx

pone.0316606.s007.docx (401.7KB, docx)

Decision Letter 2

Faiz Ahmad Joyia

15 Dec 2024

Computational and In silico study of Novel Fungicides against Combating Root Rot, Gray Mold, Fusarium Wilt, and Cereal Rust

PONE-D-24-06911R2

Dear Dr. Ajoy Kumer,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Faiz Ahmad Joyia, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Faiz Joyia

PONE-D-24-06911R2

PLOS ONE

Dear Dr. Kumer,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Faiz Ahmad Joyia

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Optimized structure of molecules.

    (DOCX)

    pone.0316606.s001.docx (2.3MB, docx)
    S2 Fig. Frontier Molecular Orbital of HOMO-LUMO for optimized structure of molecules.

    (DOCX)

    pone.0316606.s002.docx (4.2MB, docx)
    S3 Fig. Electrostatic potential map for optimized structure of molecules.

    (DOCX)

    pone.0316606.s003.docx (3.9MB, docx)
    S4 Fig. Molecular docking pose of molecules.

    (DOCX)

    pone.0316606.s004.docx (3.7MB, docx)
    Attachment

    Submitted filename: comments.docx

    pone.0316606.s005.docx (12.9KB, docx)
    Attachment

    Submitted filename: Reviewer Comments_PONE-D-24-06911.docx

    pone.0316606.s006.docx (13.3KB, docx)
    Attachment

    Submitted filename: Reviewer Comments_PONE-D-24-06911 (R2).docx

    pone.0316606.s007.docx (401.7KB, docx)

    Data Availability Statement

    All data are in the manuscript and/or supporting information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES